Tectonic Therapeutic TECX Cash Flow Statement (2017-2026)

NASDAQ TECX
$22.14 +0.31 (+1.44%)
As of: Oct 21, 2026 · 9:40 AM EDT
Reported Financials

Tectonic Therapeutic Quarterly Cash Flow Statement

Periods 37 quarters
Latest Jun 2026

Tectonic Therapeutic reported cash from operations of -$21.45M and free cash flow of -$21.53M for the quarter ended Jun 2026, down 45.7% year over year. This cash flow statement covers 37 quarters of results from Jun 2017 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow StatementCash Flow Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income
-32.61M-28.23M-29.83M-28.05M-22.97M-25.03M-14.45M-10.46M-10.05M-7.87M-15.22M-12.70M-17.72M-12.37M-15.91M-19.98M-19.04M-19.23M-25.24M-22.29M
Depreciation and DepletionDep. & Depletion
0.25M0.26M0.30M0.28M
Depreciation, Depletion & Amortization
Amortization of Deferred ChargesAmort. Deferred Charges
Depreciation & Amortization (CF)Dep. & Amort.
0.37M0.44M0.40M0.35M0.34M0.34M0.33M0.29M0.37M0.37M0.38M0.34M0.42M0.51M0.36M0.34M0.34M0.33M0.30M0.29M
Share-based CompensationStock Comp.
5.17M4.09M3.38M3.23M2.66M2.26M2.53M1.53M0.28M0.29M0.32M0.40M1.65M1.12M2.10M2.59M2.82M2.99M3.21M4.01M
Gains from Sales and DivestituresGains Divest
-0.01M0.02M0.05M-0.12M-0.01M-0.06M-0.09M-0.02M
Gains from Investment SecuritiesGains Investment
Asset Writedowns and ImpairmentWritedown
0.04M
Other non-cash itemsOther Non-Cash
-0.05M-0.06M0.03M0.04M-0.03M3.03M0.67M-0.12M0.28M0.29M0.29M0.30M0.31M-0.47M0.51M0.52M0.54M0.55M0.50M0.43M
Change in Working Capital
Change in Account PayablesChange Payables
0.94M0.52M0.55M-4.01M1.79M-1.43M0.21M1.50M2.31M-4.18M1.51M-1.58M0.09M-1.44M1.58M0.14M-1.26M-0.34M1.38M-0.80M
Change in Accured ExpensesChange Accured Exp.
4.56M-3.42M-2.88M-0.26M1.83M-2.60M-0.65M2.30M-1.88M1.85M1.38M-1.23M-2.60M-3.19M-3.42M2.26M0.03M0.57M1.63M-1.86M
Change in Other Operating AssetsOther Assets Change
3.20M-0.72M-0.33M0.40M0.09M-2.66M-2.19M2.68M-0.58M1.11M-0.31M0.14M1.41M1.41M-2.24M0.08M0.76M-1.26M0.07M1.09M
Change in Other Operating LiabilitiesOther Liabilities Change
-0.36M-0.31M-0.32M-0.33M-0.34M0.43M-0.55M-0.57M-0.58M-0.59M-0.15M-0.14M
Other Working Capital ChangesOther WC Changes
-3.20M0.72M0.33M-0.40M-0.09M2.66M2.19M-2.68M0.22M-1.42M-0.01M-0.48M-1.75M-0.98M1.68M-0.64M-1.34M0.67M-0.22M-1.23M
Cash from OperationsCash from Ops.
-24.82M-25.90M-28.01M-29.11M-16.42M-23.67M-20.28M-0.26M-8.48M-11.66M-9.27M-13.38M-19.60M-16.82M-13.08M-14.72M-17.82M-14.46M-18.41M-21.45M
Investing Activities
Capital ExpendituresCapex
0.27M0.85M0.03M0.15M0.09M0.01M0.21M0.01M0.05M0.00M0.00M0.15M0.00M0.03M0.18M0.02M0.08M
Sales of Property, Plant and EquipmentPP&E (Sale)
0.02M
Change in Property, Plant and EquipmentChange in PP&E
-0.27M-0.85M-0.03M-0.15M-0.09M-0.01M-0.21M-0.01M-0.05M0.00M0.00M-0.15M0.00M-0.03M-0.17M-0.02M-0.08M
Other Investing ActivitiesOther investing
Cash from Investing ActivitiesCash from Investing
-0.27M-0.85M-0.03M-0.15M-0.09M-0.01M-0.21M-0.01M-0.05M0.00M0.00M-0.15M0.00M-0.03M0.06M-0.17M-0.02M-0.06M
Financing Activities
Debt Issuance and Repayment
Long-Term Debt RepaymentsLT Debt Repayment
0.11M0.12M0.12M0.12M0.12M0.12M0.12M0.12M0.12M0.13M0.11M0.10M
Non-Current Debt
-0.11M-0.12M-0.12M-0.12M-0.12M-0.12M-0.12M-0.12M-0.12M-0.13M-0.11M-0.10M
Net Debt Issuances and RepaymentsNet Debt Issuance
-0.11M-0.12M-0.12M-0.12M-0.12M-0.12M-0.12M-0.12M-0.12M-0.13M-0.11M-0.10M
Change in Capital Stock
Common Stock IssuedStock Issued
0.02M0.25M0.14M0.06M0.06M0.06M-0.05M0.12M0.00M0.64M0.08M0.90M178.24M-3.98M0.01M0.06M1.36M11.86M
Shares Repurchased
Net Shares Issued and RepurchasedNet Shares Issued
0.02M0.25M0.14M0.06M0.06M0.06M-0.05M0.12M0.00M0.64M0.08M0.90M178.24M-3.98M0.01M0.06M1.36M11.86M
Net Preferred Shares Issued and RepurchasedNet Pref. Shares Issued
Net Equity Issued and RepurchasedNet Equity Issued
0.02M0.25M0.14M0.06M0.06M0.06M-0.05M0.12M0.00M0.64M0.08M0.90M178.24M-3.98M0.01M0.06M1.36M11.86M
Other financing activitiesOther financing
0.10M34.10M0.55M-0.55M0.04M0.34M0.07M-0.41M-0.08M
Cash from Financing ActivitiesCash from Financing
0.02M14.95M0.14M0.00M0.06M0.06M0.06M-0.32M-0.11M34.13M-0.67M179.74M-6.29M-1.07M178.12M-4.17M-0.46M-0.14M0.85M11.68M
Additional items
Exchange Rate EffectFX Effect
0.02M-0.08M0.02M0.02M0.04M-0.01M-0.03M-0.02M-0.04M0.09M0.00M
Change in Cash
-25.07M-11.80M-27.90M-29.25M-16.44M-23.61M-20.24M-0.80M-8.60M22.44M-10.02M166.38M-26.03M-17.86M165.01M-18.87M-18.46M-14.64M-17.49M-9.83M
Ending Cash Balance
201.86M190.06M162.16M132.90M116.46M36.55M72.61M15.52M6.92M29.36M19.34M185.71M159.68M141.83M306.83M287.97M269.51M254.87M237.38M227.55M
Free Cash FlowFCF
-25.09M-26.75M-28.05M-29.26M-16.50M-23.67M-20.29M-0.47M-8.49M-11.71M-9.28M-13.38M-19.76M-16.82M-13.11M-14.72M-18.00M-14.46M-18.43M-21.53M
Net Cash FlowNCF
-25.07M-11.80M-27.90M-29.25M-16.44M-23.61M-20.24M-0.80M-8.60M22.42M-9.95M166.36M-26.04M-17.89M165.01M-18.83M-18.44M-14.60M-17.59M-9.83M
Interest Paid
0.10M0.30M0.32M0.37M0.42M0.46M-0.38M0.04M0.03M0.06M0.05M

Tectonic Therapeutic Cash Flow Statement API

Pull Tectonic Therapeutic's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=TECX&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEY